Systematic (IUPAC) name
Clinical data
AHFS/ Micromedex Detailed Consumer Information
Pregnancy cat.  ?
Legal status Schedule IV (US) Schedule IV (International)
Routes Oral
Pharmacokinetic data
Bioavailability 93%
Metabolism Hepatic
Half-life 10-13 hours
Excretion Renal
CAS number 22232-71-9 YesY
ATC code A08AA05
PubChem CID 4020
DrugBank APRD01085
ChemSpider 3880 YesY
KEGG D00367 YesY
Chemical data
Formula C16H13ClN2O 
Mol. mass 284.74 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Mazindol (Mazanor, Sanorex) is a stimulant drug of the tetracyclic chemical class which is used as an anorectic.[1] It was developed by Sandoz-Wander in the 1960s[2]



Mazindol is used in short-term (i.e., a few weeks) treatment of exogenous obesity, in combination with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in patients with a body mass index of 30 kg of body weight per height in meters squared (kg/m2), or in patients with a body mass index of 27 kg/m2 in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia.


Mazindol is a sympathomimetic amine, which is similar to amphetamine. It stimulates the central nervous system, which increases heart rate and blood pressure, and decreases appetite. Sympathomimetic anoretics (appetite suppressants) are used in the short-term treatment of obesity. Their appetite-reducing effect tends to decrease after a few weeks of treatment. Because of this, these medicines are useful only during the first few weeks of a weight-loss program.

Although the mechanism of action of the sympathomimetics in the treatment of obesity is not fully known, these medications have pharmacological effects similar to those of amphetamines. Like other sympathomimetic appetite suppressants, mazindol is thought to act as a reuptake inhibitor of norepinephrine. In addition, it inhibits dopamine and serotonin reuptake. The recommended dosage is 2 mg per day for 90 days in patients with 40 kg of overweight or less, 4 mg a day in patients with more of 50 kg of overweight, separated in two ingestion with a 12 hour window between each 2 mg dose.


Symptoms of a mazindol overdose include: restlessness, tremor, rapid breathing, confusion, hallucinations, panic, aggressiveness, nausea, vomiting, diarrhea, an irregular heartbeat, and seizures.


Mazindol synth.svg (Satendra Singh, 2000) pages 87-90


From considering the attached QSAR table we can make the apparent observations:

  1. Desoxylation of the tertiary alcohol in mazindol improves DAT and SERT binding. The compound now behaves as a functional SNDRI instead of predominantly a noradrenaline reuptake inhibitor.
  2. Removal of the p-chloro atom in mazindol means that the compound now only behaves as a noradrenaline reuptake inhibitor.
  3. Changing the size of the imidazoline type ring system in mazindol to the corresponding six-membered homolog increases potency of the resultant compound at the DAT by approximately ten-fold.
Mazindol analogs.png
1 Cl H OH 94 4.9 43
1 Cl H H 15 6.9 6.0
1 H H OH 2140 2.8 730
1 -C4H4- OH 1.8 4.5 66
2 Cl H OH 53 4.9 3.7
2 OH H OH 60 1.9 59.0
2 OMe H OH 94 4.1 30.4
2 -OCH2O- OH 83 0.62 2.21

To make the six membered (so-called homomazindol) analog, one can simply substitute 1,2-diaminoethane with 1,3-diaminopropane. Importantly, another procedure was also published.

Given the data in the above table, one might also be interested in making the desoxy-mazindol analog. The synthesis for this is facile. Although "mazindane" is relatively stable in air, it is readily oxidized to mazindol upon contact with monoamine oxidaze enzymes present at the DAT.

See also: SNDRI for context.

See also


  1. ^ Carruba, Michele O.; Zambotti, Fernanda; Vicentini, Lucia; Picotti, Giovanni B.; Mantegazza, Paolo (1978). "Pharmacology and biochemical profile of a new anorectic drug: mazindol". Cent. Mech. Anorectic Drugs: 145–64. 
  2. ^ US Patent 3597445 - 1H-Isoindole Intermediates
  3. ^ Houlihan, WJ; Ahmad, UF; Koletar, J; Kelly, L; Brand, L; Kopajtic, TA (2002). "Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter". Journal of Medicinal Chemistry 45 (19): 4110–8. doi:10.1021/jm010301z. PMID 12213054.  editHoulihan, WJ; Kelly, L; Pankuch, J; Koletar, J; Brand, L; Janowsky, A; Kopajtic, TA (2002). "Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter". Journal of Medicinal Chemistry 45 (19): 4097–109. doi:10.1021/jm010302r. PMID 12213053.  edit

Wikimedia Foundation. 2010.

Look at other dictionaries:

  • mazindol — mazìndōl (mazindȏl) m <G mazindóla> DEFINICIJA farm. sredstvo koje uzrokuje smanjenje apetita ETIMOLOGIJA tvorničko ime proizvoda© …   Hrvatski jezični portal

  • mazindol — Anoréxico prescrito para disminuir el apetito en el tratamiento de la obesidad exógena. Diccionario Mosby Medicina, Enfermería y Ciencias de la Salud, Ediciones Hancourt, S.A. 1999 …   Diccionario médico

  • Mazindol — Strukturformel Allgemeines Freiname Ma …   Deutsch Wikipedia

  • Mazindol — МАЗИНДОЛ ( Маzindol )*. 5 (4 Хлорфенил) 2,5 дигидро 3Н имидазол[2,1 а] изоиндол 5 ол. Синонимы: Теренак, Теронак, Аfilan, Dimagrir, Мagrilan, Samonter, Sanoreх, Теrenac. По химической структуре отличается от фепранона и дезопимона, но по действию …   Словарь медицинских препаратов

  • mazindol — noun A tricyclic central nervous system stimulant used to treat obesity …   Wiktionary

  • mazindol — An isoindole anorexiant that is distinctive in not having the phenethylamine chain common to sympathomimetic amines. * * * ma·zin·dol mā zin .dōl n an adrenergic drug C16H13ClN2O used as an appetite suppressant * * * ma·zin·dol (maґzin dol) [USP] …   Medical dictionary

  • Ciclazindol — Systematic (IUPAC) name 10 (3 chlorophenyl) 3,4 dihydro 2H pyrimido[1,2 a]indol 10 ol Clinical data Pregnancy cat.  ? …   Wikipedia

  • Amineptine — chemical structure Systematic (IUPAC) name 7 [(10,11 dihydro 5H dibenzo[a,d] cyclohepten 5 yl)amino]heptanoic acid Clinica …   Wikipedia

  • D-161 — Systematic (IUPAC) name 4 ((((3S,6S) 6 benzhydryltetrahydro 2H pyran 3 yl)amino)methyl)phenol Clinical data Pregnancy cat …   Wikipedia

  • Monoamine oxidase inhibitor — MAOI redirects here. For the Easter Island statues, see Moai. Monoamine oxidase Monoamine oxidase inhibitors (MAOIs) are a class of antidepressant drugs prescribed for the treatment of depression. They are particularly effective in treating… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.